Latest news about OncoLens
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
OncoLens has secured a capital investment from Cross-Border Impact Ventures, a Canada-based impact venture fund, to fuel its international growth. This investment will help OncoLens expand its footprint into rural communities and low-middle income countries, enhancing global collaboration and access to cutting-edge oncology solutions[1].
OncoLens raised $16 million in a Series B funding round co-led by BIP Capital and Cross Border Impact Ventures, with participation from existing investors Martin Ventures and SeedToB. This funding supports the company's continued growth in optimizing cancer treatment planning and expanding its international customer base, including the EMEA region and future plans for Sub-Saharan Africa[5].
OncoLens has launched OncoLens Analytics and advanced Patient ID solutions, enabling real-time oncology patient identification for clinical trials and key services. This innovation integrates data from multiple sources, including EMRs and lab results, to provide healthcare teams with timely alerts and reports, optimizing cancer treatment planning and reducing patient leakage[1].
Open job positions at OncoLens
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.